Invest Now
Samco Star Rating Ads

Price Performance

  • Day's Low
  • ₹461.25
  • Day's High
  • ₹559.8
₹ 551.75
  • 52-w low
  • ₹286
  • 52-w high
  • ₹559.8
551.75
  • Day's open
    ₹470
  • Previous close
    ₹473.799988
  • VWAP
    ₹526.88
  • Lower price band
    ₹379.05
  • Upper price band
    ₹568.55

Today's Market Action

The last traded share price of Solara Active Pharma Sciences Ltd was 551.75 up by 16.45% on the NSE. Its last traded stock price on BSE was 551.45 up by 16.32%. The total volume of shares on NSE and BSE combined was 6,454,379 shares. Its total combined turnover was Rs 340.07 crores.

Medium and Long Term Market Action

Solara Active Pharma Sciences Ltd hit a 52-week high of 559.8 on 19-04-2024 and a 52-week low of 286 on 01-11-2023. The stock price of Solara Active Pharma Sciences Ltd is up by 48% over the last one month. It is up by 47.92% over the last one year. Don't forget to check the full stock price history in the table below.

Fundamentals

  • Market Cap (Cr): 1986

  • Book Value (₹):

  • Stock P/E:

  • Revenue (Cr):

  • Total Debt (Cr):

  • Face Value (₹):

  • Roce (%):

  • ROE (%):

  • Earnings (Cr):

  • Promoter’s Holdings (%):

  • EPS (₹):

  • Debt to Equity:

  • Dividend Yield (%):

  • Cash (Cr):

Mutual fund holdings and trends

FUND NAME Quantity Monthly Change (Qty)

Shareholding Pattern

Similar Stocks

Company Price Market Cap (Cr) P/E

About

Data not available.

FAQ's

What is Share Price of Solara Active Pharma Sciences Ltd?

What is the Market Cap of Solara Active Pharma Sciences Ltd?

What is PE Ratio of Solara Active Pharma Sciences Ltd?

What is PB Ratio of Solara Active Pharma Sciences Ltd?

What is the CAGR of Solara Active Pharma Sciences Ltd?

How to Buy Solara Active Pharma Sciences Ltd Share?

(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)
(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Net Profit)

Standalone Financial Performace In Graph(Net Profit)

(*All values are in Rs. Cr)

Consolidated Financial Performace In Graph(Cash Flow)

Standalone Financial Performace In Graph(Cash Flow)

Pros

  • Above Average Growth Rate
    The company is estimated to grow its earnings at a reasonable rate over the next few years which will drive shareholder value creation

Cons

  • Momentum Strength
    The stock is currently exhibiting weak momentum, & is showing weak relative strength.
  • Low Sustainable RoE
    The company's sustainable return on equity is lower than the expected cost of capital which implies that the underlying business will destruct value over a period of time due to it's inability to generate superior returns on capital.
  • Low Return on Capital Employed
    The company is unable to generate sufficient return on capital employed which impairs it's ability to generate high return for shareholders after accounting for taxes, interest and other non-equity stakeholders.
  • Low Interest Coverage
    The company has a very low Interest coverage ratio of 1.49 times which implies that a large portion of operating profits are getting attributed to payment of interest to debtholders. This leaves lower earnings and cash flows for equity shareholders which is negative for returns.
  • Highly Cyclical Industry
    The company operates an extremely cyclical business with unpredictable earnings and cash flows. This shall result in very high stock price volatility and returns which would negatively impact shareholder returns.
  • Low Pricing Power & High Competition
    The business has extremely low pricing power and is vulnerable to competitive pressure which can significantly impact shareholder returns.
  • Capital Intensive Business
    The company operates an extremely capital intensive business with a low Asset turnover ratio of 0.90. A low asset turnover ratio negatively impacts RoE and reduces shareholder returns. Also due to the capital intensive nature of business, growth of the business would need to be funded either via increasing borrowings or diluting shareholders, both of which shall negatively impact shareholder value and returns.
  • Poor Working Capital Cycle
    The company has a very poor working capital cycle of 281 days which requires very high investments in working capital. This reduces free cash flow generation for the business and negatively impacts shareholder value and returns.
  • High Promoter Pledge
    The company has a relatively high promoter pledge to the extent of 43% of the total company's shareholding which can have a significantly negative impact on stock.
  • Negative Margin of Safety
    The relative margin of safety of investing in the company is low due to a recent sharp run up in stock prices.

Valuation Analysis

Margin of safety
(20/04/2024)
Stock Valuation
Yellow line
86
87.50%
87.50% People are bullish about Solara Active Pharma Sciences Ltd
12.50%
12.50 % People are bearish about Solara Active Pharma Sciences Ltd

What is your opinion about this Stock?

Historical Data

Samco Star Rating Ads

Solara Active Pharma Sciences Ltd

551.75 +77.95 (16.45%)

Brokerage & Taxes at Samco

Brokerage & Taxes at Other traditional broker

Potential Brokerage Savings with Samco ₹ 49.62()

Top Gainers (NIFTY 50)

Stock Name Change %

    Top Losers (NIFTY 50)

    Stock Name Change %